Connect your AI

The Beauty Health Company SKIN Price / book

Price / book at other companies

AbbVieABBV

261×+221×

Solesence, Inc. Common StockSLSN

3.9×—

Lifevantage CorporationLFVN

1.7×-3.7×

Estee Lauder Companies Inc.EL

6.5×+1.0×

NuSkin EnterprisesNUS

0.4×0.0×

KenvueKVUE

3.1×-1.4×

Other financials

Income statement

Revenue$64.9M-6.7%

Gross profit$44.4M-8.5%

Operating income-$1.8M+85.0%

Net income-$6.6M+34.3%

EPS (diluted)-$0.05+37.5%

Balance sheet

Cash & equivalents$204.4M-45.2%

Total debt$125.9M+756%

Total equity$55.2M+19.9%

Total assets$473.2M-29.8%

Cash flow

Operating cash flow-$5.6M-285%

CapEx$224.0K+398%

Free cash flow-$5.8M-296%

Valuation

Market cap$89.75M-63.3%

Enterprise value$11.24M-97.3%

P/S0.3×-0.5×

Profitability

Gross margin64.9%+8.3pp

Operating margin-3.6%-1.6pp

Net margin-2%-0.9pp

FCF margin9.6%—

Returns & leverage

Return on equity-12%-5.4pp

Debt / equity2.3×+2.0×

Current ratio1.8×-5.7×

Where this comes from

Calculated from The Beauty Health Company’s reported figures.

market cap/total stockholders equity=2.1×

Based on the most recent quarter.

The official record: The Beauty Health Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Beauty Health Company's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is The Beauty Health Company's price / book?: The Beauty Health Company (SKIN) reported price / book of 2.1× in Q1 2026.
How has The Beauty Health Company's price / book changed year-over-year?: The Beauty Health Company's price / book decreased by 43.5% year-over-year, from 3.6× to 2.1×.
What is the long-term trend for The Beauty Health Company's price / book?: Over 4 years (2021 to 2025), The Beauty Health Company's price / book has grown at a -30.2% compound annual growth rate (CAGR), from 12.2× to 2.9×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.